“In this large, multicenter, real-world study including both academic and community practices using standard-of-care reports, histologic inflammation — despite endoscopic remission — independently conveyed a two-fold increased risk for subsequent relapse within a year,” Benjamin Click, assistant professor at the University of Colorado Crohn’s and Colitis Center and School of Medicine, told Healio.